PH vs PMCB · P/E 28, rev $19.85B vs $8.6M cap
Parker-Hannifin Corporation (PH) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the PH and PMCB stock pages for the full models.
Not investment advice.